跳至主要内容
临床试验/IRCT20120516009772N2
IRCT20120516009772N2招募中3 期

The Efficacy and side effects of different doses of finastride/ dutastride accompanying with tamsulosin for Benign prostate hyperplasia in Iranian men

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 175 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
175

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
55 years 至 75 years(—)
性别
Male

入选标准

  • prostate size larger than 30 gram
  • moderate to sever symptom (ipss>13)
  • older than 55 years old
  • Qmax of 4–15 mL/s from a pre-void bladder volume =150 and =550 mL (minimum voided volume 125 mL)
  • with >6 months history of BPH-LUTS

排除标准

  • no surgical indication(bladder stone,uremia,urinary retention,gross hematuria,recurrent infection)
  • no previous prostate surgery
  • no urethral stricture
  • history of severe renal or hepatic insuf?ciency
  • History of bladder cancer or prostate cancer

研究者

相似试验

Effect of finastride/ dutastride accompanying with... | 临床试验